Nicolò E - Search Results

1

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them.

Foffano L, Cucciniello L, Nicolò E, Migliaccio I, Noto C, Reduzzi C, Malorni L, Cristofanilli M, Gerratana L, Puglisi F. Foffano L, et al. Among authors: nicolo e. Breast. 2024 Dec 16;79:103863. doi: 10.1016/j.breast.2024.103863. Online ahead of print. Breast. 2024. PMID: 39718288 Free article. Review.

2

Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer.

Munoz-Arcos LS, Nicolò E, Serafini MS, Gerratana L, Reduzzi C, Cristofanilli M. Munoz-Arcos LS, et al. Among authors: nicolo e. Int Rev Cell Mol Biol. 2023;381:1-21. doi: 10.1016/bs.ircmb.2023.07.005. Epub 2023 Sep 1. Int Rev Cell Mol Biol. 2023. PMID: 37739480 Review.

3

Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine.

Nicolò E, Gianni C, Curigliano G, Reduzzi C, Cristofanilli M. Nicolò E, et al. Curr Opin Oncol. 2024 Nov 1;36(6):503-513. doi: 10.1097/CCO.0000000000001082. Epub 2024 Jul 15. Curr Opin Oncol. 2024. PMID: 39011731 Review.

4

Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?

Gianni C, Nicolò E, Cristofanilli M. Gianni C, et al. Among authors: nicolo e. Transl Breast Cancer Res. 2024 Oct 25;5:34. doi: 10.21037/tbcr-24-41. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 39534583 Free PMC article. No abstract available.

5

Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer.

Nicolò E, Gianni C, Pontolillo L, Serafini MS, Munoz-Arcos LS, Andreopoulou E, Curigliano G, Reduzzi C, Cristofanilli M. Nicolò E, et al. Transl Breast Cancer Res. 2024 Apr 26;5:10. doi: 10.21037/tbcr-23-55. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751670 Free PMC article. Review.

6

Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion.

Nicolò E, Munoz-Arcos L, Vagia E, D'Amico P, Reduzzi C, Donahue J, Lorico-Rappa M, Manai M, Behdad A, Zhang Y, Curigliano G, Shah A, Cristofanilli M. Nicolò E, et al. JCO Precis Oncol. 2023 Jul;7:e2200702. doi: 10.1200/PO.22.00702. JCO Precis Oncol. 2023. PMID: 37437229 No abstract available.

7

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

Reduzzi C, Nicolo' E, Singhal S, Venetis K, Ortega-Franco A, de Miguel-Perez D, Dipasquale A, Gouda MA, Saldanha EF, Kasi PM, Jantus-Lewintre E, Fusco N, Malapelle U, Gandara DR, Rolfo C, Serrano MJ, Cristofanilli M; International Society of Liquid Biopsy (ISLB). Reduzzi C, et al. Among authors: nicolo e. Crit Rev Oncol Hematol. 2024 Nov;203:104483. doi: 10.1016/j.critrevonc.2024.104483. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159706 Review.

8

Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.

Valenza C, Trapani D, Zagami P, Antonarelli G, Boscolo Bielo L, Nicolò E, Ribeiro JM, Guidi L, Reduzzi C, Spotti M, Adamoli L, Cortès J, Pistilli B, Tolaney SM, Ueno N, Layman RM, Cristofanilli M, Carey LA, Munzone E, Criscitiello C, Lynce F, Woodward WA, Curigliano G. Valenza C, et al. Among authors: nicolo e. Eur J Cancer. 2024 Dec;213:115097. doi: 10.1016/j.ejca.2024.115097. Epub 2024 Oct 28. Eur J Cancer. 2024. PMID: 39486164

9

Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives.

Nicolò E, Giugliano F, Ascione L, Tarantino P, Corti C, Tolaney SM, Cristofanilli M, Curigliano G. Nicolò E, et al. Cancer Treat Rev. 2022 May;106:102395. doi: 10.1016/j.ctrv.2022.102395. Epub 2022 Apr 18. Cancer Treat Rev. 2022. PMID: 35468539 Review.

10

Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance.

Corvaja C, Taurelli Salimbeni B, Nicolò E, Puglisi F, Curigliano G. Corvaja C, et al. Among authors: nicolo e. Expert Opin Pharmacother. 2022 Nov;23(16):1765-1770. doi: 10.1080/14656566.2022.2139176. Epub 2022 Nov 3. Expert Opin Pharmacother. 2022. PMID: 36268855 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters